T. Constantin

A cell-cycle signature classifier for pan-cancer analysis

J. Stebbing, N. Tabassum, T. Constantin, 2020, Oncogene.

Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer

T. Constantin, A. Varela-Carver, C. Bevan, 2022, Oncogene.

The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer

Simak Ali, Lucy Penfold, D. Carling, 2022, bioRxiv.

A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer

D. Leach, K. Knudsen, T. Constantin, 2022, Molecular cancer.

AMPK activation protects against prostate cancer by inducing a catabolic cellular state.

D. Leach, A. Nikitin, Alice E. Pollard, 2023, Cell reports.

A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer

D. Leach, K. Knudsen, T. Constantin, 2022, Molecular Cancer.